Science Explorer Interactive view Map
Company · Cambridge · United States

Edimer Pharmaceuticals (United States)

edimerpharma.comROR OpenAlex
Research works
42
▼ 58% vs 2013–17
Citations
1.6k
39.2 per fractional work
Top-10% rate
10.6%
record average 16.5%
Open access
38%
world 28%

Not ranked overall: Edimer Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.38× its world share, 0 worksBiochemistry, Geneti…Computer Science: 0.82× its world share, 0 worksComputer ScienceEngineering: 0.21× its world share, 0 worksEngineeringMedicine: 1.06× its world share, 1 worksMedicineArts and Humanities: 4.96× its world share, 0 worksArts and HumanitiesSocial Sciences: 3.40× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Arts and Humanities, 5.0×. Every wedge is a field page.

Which keywords describe research at Edimer Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Healthcare-Associated Infections, Epidemiology, Clinical Practice Guidelines, Risk Factors, Antibiotic-Associated Diarrhea, Fecal Microbiota Transplantation, Cancer and Epithelial-Mesenchymal Interactions.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Epidemiology8▲ 4.8×11 topics
  2. Healthcare-Associated Infections6▲ 127×4 topics
  3. Clinical Practice Guidelines4▲ 19×2 topics
  4. Risk Factors4▲ 10×2 topics
  5. Antibiotic-Associated Diarrhea4▲ 386×1 topic
  6. Cancer4▲ 7.5×10 topics
  7. Fecal Microbiota Transplantation4▲ 386×1 topic
  8. Epithelial-Mesenchymal Interactions3▲ 200×2 topics
  9. Inflammation3▲ 3.1×14 topics
  10. Epidemiological Study3▲ 89×2 topics
  11. Molecular Signaling3▲ 309×1 topic
  12. Tooth Development3▲ 309×1 topic
  13. Collagenous Colitis3▲ 263×1 topic
  14. Microscopic Colitis3▲ 263×1 topic
  15. Prevention3▲ 16×2 topics
  16. Antibiotic Resistance2▲ 12×4 topics
  17. Child Care2▲ 119×1 topic
  18. Infection Control Measures2▲ 119×1 topic
  19. Pathogenesis2▲ 7.6×4 topics
  20. Staphylococcus aureus2▲ 46×2 topics
  21. Glycosidase Inhibitors1▲ 68×1 topic
  22. Oligosaccharide Synthesis1▲ 68×1 topic
  23. Therapeutic Targets1▲ 13×4 topics
  24. Arginine Methylation1▲ 91×1 topic
  25. Protein Arginine Methyltransferases1▲ 91×1 topic
  26. Ribosome1▲ 30×1 topic
  27. Translation1▲ 14×1 topic
  28. Virulence Factors1▲ 15×2 topics
  29. Homologous Recombination1▲ 40×2 topics
  30. Microbiota1▲ 12×2 topics
  31. Probiotics1▲ 11×2 topics
  32. Colonialism1▲ 4.8×2 topics
  33. Genitourinary Development1▲ 50×1 topic
  34. ICU1▲ 89×1 topic
  35. Urotrauma1▲ 50×1 topic
  36. Ventilator-associated Pneumonia1▲ 89×1 topic

Which research topics does Edimer Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Cultural Identity and Heritage, Diverse Cultural and Historical Studies, Sports, Gender, and Society and Sport and Mega-Event Impacts.

Cultural Identity and Heritage: 0 fractional worksDiverse Cultural and Historical Studies: 0 fractional worksSports, Gender, and Soci…0Sports, Gender, and Society: 0 fractional worksSport and Mega-Event Imp…0Sport and Mega-Event Impacts: 0 fractional worksFrench Urban and Social Studies: 0 fractional worksMetabolism, Diabetes, and Cancer: 0 fractional worksAdenosine and Purinergic…0Adenosine and Purinergic Signaling: 0 fractional worksPARP inhibition in cancer therapy: 0 fractional worksFrailty in Older Adults: 0 fractional worksAdvanced Neural Network Applications: 0 fractional works
ArcheologyCultural StudiesGender StudiesSociology and Political Science5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cultural Identity and Heritage Archeology 0 works
  2. 2 Diverse Cultural and Historical Studies Cultural Studies 0 works
  3. 3 Sports, Gender, and Society Gender Studies 0 works
  4. 4 Sport and Mega-Event Impacts Sociology and Political Science 0 works
  5. 5 French Urban and Social Studies Sociology and Political Science 0 works
  6. 6 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
  7. 7 Adenosine and Purinergic Signaling Physiology 0 works
  8. 8 PARP inhibition in cancer therapy Oncology 0 works
  9. 9 Frailty in Older Adults Geriatrics and Gerontology 0 works
  10. 10 Advanced Neural Network Applications Computer Vision and Pattern Recognition 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.8%not open62.2%

World: 28% of research is openly available.

with international co-authors29.3%domestic only70.7%

World: 19% is written across borders.

How has Edimer Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 58% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.